Investigational topical anticholinergics in clinical development for the treatment of hyperhidrosis

Expert Opin Investig Drugs. 2021 May;30(5):479-482. doi: 10.1080/13543784.2021.1900114. Epub 2021 Apr 16.

Authors

Stamatios Gregoriou¹, Anna Campanati², Dimitrios Rigopoulos¹, Anna Maria Offidani¹, Alexandros Stratigos¹, George Kontochristoulos¹

Affiliations

¹ Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece.
² Department of Clinical and Molecular Sciences, Polytechnic Marche University, Dermatology Clinic, Ancona, Italy.

PMID: 33691553
DOI: 10.1080/13543784.2021.1900114

No abstract available

Keywords: Adverse events; efficacy; glycopyrrolate; oxybutynin; sofpironium; therapy; umeclidinium.

Publication types

Editorial

MeSH terms

Administration, Topical
Cholinergic Antagonists / administration & dosage*
Cholinergic Antagonists / pharmacology
Drug Development
Drugs, Investigational / administration & dosage
Drugs, Investigational / pharmacology
Humans
Hyperhidrosis / drug therapy*

Substances

Cholinergic Antagonists
Drugs, Investigational